2,126
Views
29
CrossRef citations to date
0
Altmetric
Articles

Comparing three stages of addiction recovery: long-term recovery and its relation to housing problems, crime, occupation situation, and substance use

, ORCID Icon, , , ORCID Icon & ORCID Icon
Pages 387-396 | Received 23 Oct 2019, Accepted 03 Jun 2020, Published online: 24 Jun 2020
 

Abstract

Many studies on addiction recovery focus on recovery initiation and short-term outcomes for alcohol addictions. In this study, we examine associations between three recovery stages and recovery markers for persons in drug addiction recovery. Data were collected for a multi-country study (REC-PATH) among 722 individuals living in the UK, the Netherlands, and Belgium, who consider themselves in addiction recovery for a period of three months or more. We focus on typical life domains that characterize recovery: housing, crime, work or education, and substance use. The relation with time in recovery was examined for three recovery stages: early (<1 year), sustained (1–5 years), and stable (>5 years). Using the Life in Recovery survey, cross-sectional analyses reveal that participants in later recovery stages have lower odds of having housing problems, being involved in crime, and using illicit hard drugs and higher odds of having work or education, when compared to participants in the early recovery stage. This study provides further empirical support for defining drug addiction recovery as a gradual, long-term process that is associated with various life domains beyond abstinence. The findings suggest that drug policy, treatment and research need to be oriented towards long-term objectives and recovery goals that cover multiple life domains in order to support stable recovery.

Disclosure statement

No potential conflict of interest was reported by the author(s).

Data availability statement

The data that support the findings of this study are available from the corresponding author, TM, upon reasonable request.

Additional information

Funding

.REC-PATH is a collaborative project supported by the European Research Area Network on Illicit Drugs (ERANID).This work is funded in the UK by the National Institute for Health Research (NIHR) Policy Research Programmeand Scottish Government, in Belgium by the Belgian Science Policy Office (BELSPO) and Research Foundation- Flanders (FWO), and in the Netherlands by the Netherlands Organisation for Health Research & Development(ZonMw). The views expressed in this article are those of the authors and not necessarily those of the nationalfunding agencies or ERANID.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.